Traynor Capital Management, Inc.
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1666786
MALVERN, PA
Position in ESPR
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$45,459
+$45,459 QoQ
Shares Held
14,386
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 40 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Traynor Capital Management, Inc. holds $62,103 across 2 Drug Manufacturers - Specialty & Generic names. ESPR ranks #1 (73.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ESPR |
Esperion Therapeutics, Inc.
This page
|
14,386 | $45,459 | |
| 2 | AKBA |
Akebia Therapeutics, Inc.
|
14,600 | $16,644 |
All Filings in ESPR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,459 | 14,386 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | — | 14,386 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | — | 14,386 | Shares | Sole | 2026-01-12 | |
| No filing history on record for this holder in this stock. | ||||||